新たに診断された多形性膠芽腫の高齢患者に対する放射線療法（テモゾロミド併用または非併用）

基本情報

NCT ID

NCT00482677

ステータス

完了

試験のフェーズ

第3相

試験タイプ

介入

目標被験者数

562

治験依頼者名

Canadian Cancer Trials Group

概要

RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving radiation therapy together with temozolomide may kill more tumor cells. It is not yet known whether radiation therapy and temozolomide are more effective than radiation therapy alone in treating glioblastoma multiforme. PURPOSE: This randomized phase III trial is studying radiation therapy and temozolomide to see how well they work compared with radiation therapy alone in treating patients with newly diagnosed glioblastoma multiforme.

対象疾患

介入

依頼者（Sponsor）

実施施設 (1)